Skip to main content
. 2021 Feb 2;11:2792. doi: 10.1038/s41598-021-82502-y

Figure 1.

Figure 1

(a) Evolution of the serum NTX concentration after administration of a single dose of denosumab and comparison with Marathe’s work33 and with experiments36; (b) evolution of the plasma concentration after administration of a single dose of denosumab and comparison with Marathe’s work33 and with experiments36; (c) changes in the concentration of urine CTX from the baseline after administration of a single dose of Ibandronate and comparison with Marathe’s work8 and with experiments35.